Differences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sites

Abstract Circulating microRNAs are non-invasive biomarkers that can be used for breast cancer diagnosis. However, differences in cancer tissue microRNA expression are observed in populations with different genetic/environmental backgrounds. This work aims at checking if a previously identified diagn...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jeanne P. Uyisenga, Ahmed Debit, Christophe Poulet, Pierre Frères, Aurélie Poncin, Jérôme Thiry, Leon Mutesa, Guy Jerusalem, Vincent Bours, Claire Josse
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d916c08b576f43a2930a6c35039f5062
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d916c08b576f43a2930a6c35039f5062
record_format dspace
spelling oai:doaj.org-article:d916c08b576f43a2930a6c35039f50622021-12-02T15:56:49ZDifferences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sites10.1038/s41598-021-91278-02045-2322https://doaj.org/article/d916c08b576f43a2930a6c35039f50622021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91278-0https://doaj.org/toc/2045-2322Abstract Circulating microRNAs are non-invasive biomarkers that can be used for breast cancer diagnosis. However, differences in cancer tissue microRNA expression are observed in populations with different genetic/environmental backgrounds. This work aims at checking if a previously identified diagnostic circulating microRNA signature is efficient in other genetic and environmental contexts, and if a universal circulating signature might be possible. Two populations are used: women recruited in Belgium and Rwanda. Breast cancer patients and healthy controls were recruited in both populations (Belgium: 143 primary breast cancers and 136 healthy controls; Rwanda: 82 primary breast cancers and 73 healthy controls; Ntot = 434), and cohorts with matched age and cancer subtypes were compared. Plasmatic microRNA profiling was performed by RT-qPCR. Random Forest was used to (1) evaluate the performances of the previously described breast cancer diagnostic tool identified in Belgian-recruited cohorts on Rwandan-recruited cohorts and vice versa; (2) define new diagnostic signatures common to both recruitment sites; (3) define new diagnostic signatures efficient in the Rwandan population. None of the circulating microRNA signatures identified is accurate enough to be used as a diagnostic test in both populations. However, accurate circulating microRNA signatures can be found for each specific population, when taken separately.Jeanne P. UyisengaAhmed DebitChristophe PouletPierre FrèresAurélie PoncinJérôme ThiryLeon MutesaGuy JerusalemVincent BoursClaire JosseNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jeanne P. Uyisenga
Ahmed Debit
Christophe Poulet
Pierre Frères
Aurélie Poncin
Jérôme Thiry
Leon Mutesa
Guy Jerusalem
Vincent Bours
Claire Josse
Differences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sites
description Abstract Circulating microRNAs are non-invasive biomarkers that can be used for breast cancer diagnosis. However, differences in cancer tissue microRNA expression are observed in populations with different genetic/environmental backgrounds. This work aims at checking if a previously identified diagnostic circulating microRNA signature is efficient in other genetic and environmental contexts, and if a universal circulating signature might be possible. Two populations are used: women recruited in Belgium and Rwanda. Breast cancer patients and healthy controls were recruited in both populations (Belgium: 143 primary breast cancers and 136 healthy controls; Rwanda: 82 primary breast cancers and 73 healthy controls; Ntot = 434), and cohorts with matched age and cancer subtypes were compared. Plasmatic microRNA profiling was performed by RT-qPCR. Random Forest was used to (1) evaluate the performances of the previously described breast cancer diagnostic tool identified in Belgian-recruited cohorts on Rwandan-recruited cohorts and vice versa; (2) define new diagnostic signatures common to both recruitment sites; (3) define new diagnostic signatures efficient in the Rwandan population. None of the circulating microRNA signatures identified is accurate enough to be used as a diagnostic test in both populations. However, accurate circulating microRNA signatures can be found for each specific population, when taken separately.
format article
author Jeanne P. Uyisenga
Ahmed Debit
Christophe Poulet
Pierre Frères
Aurélie Poncin
Jérôme Thiry
Leon Mutesa
Guy Jerusalem
Vincent Bours
Claire Josse
author_facet Jeanne P. Uyisenga
Ahmed Debit
Christophe Poulet
Pierre Frères
Aurélie Poncin
Jérôme Thiry
Leon Mutesa
Guy Jerusalem
Vincent Bours
Claire Josse
author_sort Jeanne P. Uyisenga
title Differences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sites
title_short Differences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sites
title_full Differences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sites
title_fullStr Differences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sites
title_full_unstemmed Differences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sites
title_sort differences in plasma microrna content impair microrna-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sites
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/d916c08b576f43a2930a6c35039f5062
work_keys_str_mv AT jeannepuyisenga differencesinplasmamicrornacontentimpairmicrornabasedsignatureforbreastcancerdiagnosisincohortsrecruitedfromheterogeneousenvironmentalsites
AT ahmeddebit differencesinplasmamicrornacontentimpairmicrornabasedsignatureforbreastcancerdiagnosisincohortsrecruitedfromheterogeneousenvironmentalsites
AT christophepoulet differencesinplasmamicrornacontentimpairmicrornabasedsignatureforbreastcancerdiagnosisincohortsrecruitedfromheterogeneousenvironmentalsites
AT pierrefreres differencesinplasmamicrornacontentimpairmicrornabasedsignatureforbreastcancerdiagnosisincohortsrecruitedfromheterogeneousenvironmentalsites
AT aurelieponcin differencesinplasmamicrornacontentimpairmicrornabasedsignatureforbreastcancerdiagnosisincohortsrecruitedfromheterogeneousenvironmentalsites
AT jeromethiry differencesinplasmamicrornacontentimpairmicrornabasedsignatureforbreastcancerdiagnosisincohortsrecruitedfromheterogeneousenvironmentalsites
AT leonmutesa differencesinplasmamicrornacontentimpairmicrornabasedsignatureforbreastcancerdiagnosisincohortsrecruitedfromheterogeneousenvironmentalsites
AT guyjerusalem differencesinplasmamicrornacontentimpairmicrornabasedsignatureforbreastcancerdiagnosisincohortsrecruitedfromheterogeneousenvironmentalsites
AT vincentbours differencesinplasmamicrornacontentimpairmicrornabasedsignatureforbreastcancerdiagnosisincohortsrecruitedfromheterogeneousenvironmentalsites
AT clairejosse differencesinplasmamicrornacontentimpairmicrornabasedsignatureforbreastcancerdiagnosisincohortsrecruitedfromheterogeneousenvironmentalsites
_version_ 1718385420877692928